Developing the Next Generation of Veterinary Therapeutics
Pet Pharma is advancing a pipeline of prescription phytopharmaceutical medicines targeting major unmet needs in companion animal healthcare.
Our Development Strategy
Using PolyNexis+™ to identify novel therapeutic formulations.
Generating robust evidence of safety and efficacy.
Pursuing approval through established pathways including:
- VMD
- EMA
- FDA
Creating licensing and acquisition opportunities with global animal-health companies.
Current Development Areas
Parasiticides
Novel approaches to parasite control addressing resistance and environmental concerns.
Pain & Osteoarthritis
Potential alternatives to chronic NSAID treatment.
Dermatology
Addressing one of the most common conditions affecting companion animals.
Oncology
Developing supportive treatments for lymphoma and related cancers.
Anxiety & Neurology
Targeting behavioural and neurological disorders.
Diabetes & Obesity
Addressing growing metabolic health challenges.
Our unique rigorously tested, phytopharmaceutical formulations are backed by scientific research; reducing harm and providing safe effective treatments for osteoarthritis, inflammation, as well as behavioural and neurological conditions.
Ultimately, we aim to provide:
Safe alternatives to conventional treatments – with minimal side effects.
Products that vets can easily prescribe.
Clinical validation for efficacy and safety
Further Information
Please fill in below to find out more